Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBS | P35520 | 2/20 | 0.78 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.78 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.78 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | PKM | P14618 | 4/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.72 |
| ▸ | APEX1 | P27695 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | RECQL | P46063 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.72 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.72 |
| ▸ | ALPL | P05186 | 1/20 | 0.72 |
| ▸ | ALPI | P09923 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | ALPG | P10696 | 1/20 | 0.72 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28986431 | 1.00 | CBS (0.78) | CBSCDK5CDK5R1PTPN1KMT2A | |
| SCHEMBL476215 | 1.00 | CBS (0.78) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Cupressuflavone SCHEMBL31670258 | 0.88 | CBS (1.00) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Cupressuflavone SCHEMBL505213 | 0.88 | CBS (1.00) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Norwogonin SCHEMBL30485998 | 0.88 | GABRP (0.68) | CBSCDK5CDK5R1PTPN1KMT2A | |
| SCHEMBL24840880 | 0.88 | KMT2A (0.72) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Norwogonin SCHEMBL760431 | 0.88 | GABRP (0.68) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Cupressuflavone SCHEMBL4650575 | 0.86 | CBS (0.97) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Hypolaetin SCHEMBL29929136 | 0.86 | BCL2 (0.69) | CBSCDK5CDK5R1PTPN1KMT2A | |
| Hypolaetin SCHEMBL29435843 | 0.86 | BCL2 (0.69) | CBSCDK5CDK5R1PTPN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220088199-A1 | METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION | SACHEM, INC. | 2022-03-24 | — | — | US | claimed |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| US-12453799-B1 | Bioadhesive for medical and dental applications | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-10-28 | — | — | US | disclosed |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-08-07 | — | — | US | disclosed |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-06-03 | — | — | US | disclosed |
| US-20250090435-A1 | PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS | SACHEM, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-09-05 | — | — | US | disclosed |
| EP-4376798-A1 | PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS | Sachem, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-117813075-A | Preservative for cosmetic and pharmaceutical compositions | 赛成公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20230210931-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-07-06 | — | — | US | disclosed |
| WO-2023009849-A1 | PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS | SACHEM, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| CN-115403589-A | Separation and purification method of homoharringtonine | 李玉山 | 2022-11-29 | — | — | CN | disclosed |
| US-11376570-B1 | Method of forming copper oxide-on-copper nanomaterial catalyst mesh | KING ABDULAZIZ UNIVERSITY (SA) | 2022-07-05 | — | — | US | disclosed |
| US-11311492-B1 | Carbon nanomedicine with natural ligands | KING ABDULAZIZ UNIVERSITY (SA) | 2022-04-26 | — | — | US | disclosed |
| EP-3981442-A1 | MOBILE DEVICE OPERABLE BY MEANS OF A TEMPERATURE DIFFERENCE FOR CLEANING AND DISINFECTING ROOM AIR | Münch, Elke (DE) | 2022-04-13 | — | — | EP | disclosed |
| EP-3978038-A1 | MOBILE DEVICE OPERABLE BY MEANS OF A TEMPERATURE DIFFERENCE FOR CLEANING AND DISINFECTING ROOM AIR AND TEST DEVICE FOR SAME | Münch, Elke (DE) | 2022-04-06 | — | — | EP | disclosed |
| US-20220088199-A1 | METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION | SACHEM, INC. | 2022-03-24 | — | — | US | disclosed |
| US-11234940-B1 | Method for making a noble metal nanomedicine | KING ABDULAZIZ UNIVERSITY (SA) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090435-A1 | PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS | PLOD2, CUTA, PHOSPHO1 | CBS 2850/4885CDK5 3594/4885CDK5R1 3499/4885 |
| US-20220088199-A1 | METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION | GK, ABHD10, CBR3 | CBS 1334/4885CDK5 4120/4885CDK5R1 4348/4885 |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | UGGT1, G6PD, UGT1A3 | CBS 4766/4885CDK5 4036/4885CDK5R1 4479/4885 |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | CBS 4819/4885CDK5 3121/4885CDK5R1 3689/4885 |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | SLC2A3, SLC2A1, SLC2A8 | CBS 4768/4885CDK5 3784/4885CDK5R1 4282/4885 |
| US-20230210931-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | CBS 4819/4885CDK5 3121/4885CDK5R1 3689/4885 |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | UGGT1, G6PD, UGDH | CBS 4819/4885CDK5 3121/4885CDK5R1 3689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.